An Extension Trial of GW 906 in Participants With Essential Hypertension

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This clinical study was designed to assess the safety and efficacy of long-term dosing of GW906
Trial Details
NCT Number NCT07879755
Lead Sponsor Shenzhen Salubris Pharmaceuticals Co., Ltd.
Conditions
(from sponsor)		 Hypertension
Related terms Hypertension
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov